Wes Kaupinen is the founder of Palvella Therapeutics. Palvella Therapeutics has raised $45M in total funding. Latest round: Series C. Based in Wayne, USA.
Wes Kaupinen is the Founder and CEO of Palvella Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapies for rare skin diseases. He also serves as President and Director at the company, which is listed on Nasdaq under the ticker PVLA.
Full founder directory · Investor directory · Company funding database · Fundraising library